S. Delluc

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
S. Delluc, Stephanie Delluc, Stéphanie Delluc
Publication record
16 papers · 413 citations · H-index 8

PAPERS

Beta lactam hypersensitivities
20140 citationsauthor #3
A pM inhibitor of HB-EGF derived from diphtheria toxin for the treatment of HB-EGF-related diseases
20130 citationsauthor #4
Identification and frequency of circulating CD4+ T lymphocytes specific to Benzylpenicillin in healthy donors
201330 citationsauthor #2
[The prediction of immunogenicity of therapeutic proteins].
20121 citationsauthor #2
22. Engineering of an HB-EGF Inhibitor from the Diphtheria Toxin Receptor–Binding Domain for the Treatment of HB-EGF-Related Diseases
20120 citationsauthor #4
Quantitative analysis of the CD4 T‐cell repertoire specific to therapeutic antibodies in healthy donors
201168 citationsauthor #1
Quantification of the preexisting CD4 T-cell repertoire specific for human erythropoietin reveals its immunogenicity potential.
201050 citationsauthor #1
Dramatic efficacy improvement of a DC-based vaccine against AML by CD25 T cell depletion allowing the induction of a long-lasting T cell response
200935 citationsauthor #1
Depletion of Regulatory T Cells Dramatically Improves DC-Based Immunization Against Acute Myeloid Leukemia.
20062 citationsauthor #1
DC-based vaccine loaded with acid-eluted peptides in acute myeloid leukemia: the importance of choosing the best elution method
200619 citationsauthor #1
Ex Vivo Characterization of Multiepitopic Tumor-Specific CD8 T Cells in Patients with Chronic Myeloid Leukemia: Implications for Vaccine Development and Adoptive Cellular Immunotherapy1
2005114 citationsauthor #4
Adoptive Cellular Chronic Myeloid Leukemia : Implications for Tumor-Specific CD 8 T Cells in Patients with Ex Vivo Characterization of Multiepitopic
20050 citationsauthor #4
Autologous peptides eluted from acute myeloid leukemia cells can be used to generate specific antileukemic CD4 helper and CD8 cytotoxic T lymphocyte responses in vitro.
200514 citationsauthor #1
Absence or Low Expression of Fas-Associated Protein with Death Domain in Acute Myeloid Leukemia Cells Predicts Resistance to Chemotherapy and Poor Outcome
200480 citationsauthor #2
Resistance to Chemotherapy and Poor Outcome Death Domain in Acute Myeloid Leukemia Cells Predicts Absence or Low Expression of Fas-Associated Protein with Updated
20040 citationsauthor #2
Naturally Processed Peptides Eluted from Acute Myeloid Leukemia Cells : A Potent Antigen Source for Immunotherapy.
20040 citationsauthor #1

TIMELINE

2004 80 citations

2005 128 citations

2006 21 citations

2009 35 citations

2010 50 citations

2011 68 citations

2012 1 citations

2013 30 citations

2014 0 citations

S. Delluc

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT